Lexeo Therapeutics, Inc. (LXEO)
6.29
+0.02
(+0.32%)
USD |
NASDAQ |
Feb 20, 16:00
6.25
-0.04
(-0.64%)
After-Hours: 20:00
Lexeo Therapeutics Total Liabilities (Quarterly) : 23.01M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 117.67B |
| Insmed, Inc. | 1.526B |
| Eli Lilly & Co. | 85.94B |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Phathom Pharmaceuticals, Inc. | 662.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.84M |
| Shareholders Equity (Quarterly) | 120.83M |
| Debt to Equity Ratio | 0.07 |
| Current Ratio | 7.399 |
| Net Debt Paydown Yield | 0.22% |